Is this SDS the latest revision?

This Safety Data Sheet was issued by GlaxoSmithKline on 21 May 2018 under GHS/CLP. ISDSS syncs its database regularly to keep documents current.

Do I need to register to download this SDS?

Yes, a free ISDSS account is required to download the PDF. Registration takes under two minutes and gives you access to over 1.5 million Safety Data Sheets. Once registered, you can also save documents to your personal library for quick access.

Who is responsible for providing an SDS?

The manufacturer, importer or supplier that places the substance on the market is responsible for providing a current Safety Data Sheet to downstream users, free of charge.

Can I use this SDS as my COSHH risk assessment?

No. An SDS provides the hazard information you need, but a COSHH assessment must consider how the substance is actually used in your workplace. The matching Chemical Risk Assessment (CRA) on this page is a starting point you should adapt to your own tasks and controls.

Safety Data SheetChemical Risk Assessment

Tykerb Tablets

by GlaxoSmithKline

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Tykerb Tablets is supplied by GlaxoSmithKline under product code GW572016F 100 MG TABLETS, GW572016F 250 MG TABLETS. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 21 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.

Language: English
Regulation: GHS/CLP
Revision Date: 21 May 2018
Signal Word: WARNING
Product Code: GW572016F 100 MG TABLETS, GW572016F 250 MG TABLETS
CAS Number: 9004-34-6,388082-78-8,9003-39-8,557-04-0

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.